Controversies about extended-spectrum and AmpC beta-lactamases.

Many clinical laboratories have problems detecting extended-spectrum beta-lactamases (ESBLs) and plasmid-mediated AmpC beta-lactamases. Confusion exists about the importance of these resistance mechanisms, optimal test methods, and appropriate reporting conventions. Failure to detect these enzymes h...

Descripción completa

Detalles Bibliográficos
Autor principal: Thomson, K S
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2001
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631719/
https://www.ncbi.nlm.nih.gov/pubmed/11294735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631719/
https://www.ncbi.nlm.nih.gov/pubmed/11294735

Ejemplares similares